Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8902537rdf:typepubmed:Citationlld:pubmed
pubmed-article:8902537lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:8902537lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:8902537lifeskim:mentionsumls-concept:C0208407lld:lifeskim
pubmed-article:8902537lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:8902537lifeskim:mentionsumls-concept:C0095112lld:lifeskim
pubmed-article:8902537pubmed:issue5lld:pubmed
pubmed-article:8902537pubmed:dateCreated1997-2-13lld:pubmed
pubmed-article:8902537pubmed:abstractTextThe one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide, tirapazamine (SR 4233) in aqueous solution has been determined by pulse radiolysis. Reversible electron transfer was achieved between radiolytically-generated one-electron reduced radicals of tirapazamine (T), and quinones or benzyl viologen as redox standards. The reduction potential Em7(T/T-) was -0.45 +/- 0.01 V vs. NHE at pH 7 From the pH dependence of the reduction potential, pKa = 5.6 +/- 0.2 was estimated for the tirapazamine radical, a value similar to the pKa determined by other methods.lld:pubmed
pubmed-article:8902537pubmed:languageenglld:pubmed
pubmed-article:8902537pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902537pubmed:citationSubsetIMlld:pubmed
pubmed-article:8902537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902537pubmed:statusMEDLINElld:pubmed
pubmed-article:8902537pubmed:monthNovlld:pubmed
pubmed-article:8902537pubmed:issn1071-5762lld:pubmed
pubmed-article:8902537pubmed:authorpubmed-author:WardmanPPlld:pubmed
pubmed-article:8902537pubmed:authorpubmed-author:TracyMMlld:pubmed
pubmed-article:8902537pubmed:authorpubmed-author:PriyadarsiniK...lld:pubmed
pubmed-article:8902537pubmed:issnTypePrintlld:pubmed
pubmed-article:8902537pubmed:volume25lld:pubmed
pubmed-article:8902537pubmed:ownerNLMlld:pubmed
pubmed-article:8902537pubmed:authorsCompleteYlld:pubmed
pubmed-article:8902537pubmed:pagination393-9lld:pubmed
pubmed-article:8902537pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8902537pubmed:meshHeadingpubmed-meshheading:8902537-...lld:pubmed
pubmed-article:8902537pubmed:meshHeadingpubmed-meshheading:8902537-...lld:pubmed
pubmed-article:8902537pubmed:meshHeadingpubmed-meshheading:8902537-...lld:pubmed
pubmed-article:8902537pubmed:meshHeadingpubmed-meshheading:8902537-...lld:pubmed
pubmed-article:8902537pubmed:meshHeadingpubmed-meshheading:8902537-...lld:pubmed
pubmed-article:8902537pubmed:meshHeadingpubmed-meshheading:8902537-...lld:pubmed
pubmed-article:8902537pubmed:meshHeadingpubmed-meshheading:8902537-...lld:pubmed
pubmed-article:8902537pubmed:year1996lld:pubmed
pubmed-article:8902537pubmed:articleTitleThe one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine): a hypoxia-selective bioreductive drug.lld:pubmed
pubmed-article:8902537pubmed:affiliationGray Laboratory Cancer Research Trust, Mouni Vernon Hospital, Northwood, Middx, UK.lld:pubmed
pubmed-article:8902537pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8902537pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8902537lld:pubmed